Kopper L, Timar J, Kovalszky I, Fulop C, Glant T
Ist Institute of Pathology and Experimental Cancer Research, Semmelweis Medical University, Budapest, Hungary.
In Vivo. 1990 Mar-Apr;4(2):149-52.
Glycosaminoglycan and core protein components of proteoglycans (PGs) have been studied in three human non-Hodgkin lymphoma xenografts of B cell origin. Lymphomas showed similar GAG content, but different composition of GAG subtypes. This variability was accompanied by an individual capacity to adhere to extracellular matrix elements. The core proteins identified by monoclonal antibodies raised against human cartilage chondroitin sulfate PG were also distinctly expressed and released. These proteins shared by different cell types may have biological significance.